New Processes With Parallel Bioreactors By Claudia M. Huether and Dr. Falk Schneider, DASGIP AG, Jülich
The pharmaceutical industry and regulatory authorities are facing new challenges in the development of new drugs that have complex interdependencies. The following provides some insights into the more notable advantages of using process-integrated data management in tandem with parallel bioreacreactor systems.
Three Words That Can Determine Patent Ownership By Cathy Yarbrough, contributing editor
Three words that could determine ownership of an invention, “and hereby assigns,” are often missing from employment agreements in the life sciences industry.
Characterization Of Single-Use BioProcess Container™ Systems Based On HyQ® CX5-14 Film The trend towards single-use containers and systems in the biopharmaceutical process industry has led to a shift of concerns regarding the cleaning and sterilization of conventional multiuse containers and systems to those regarding material characteristics and container/content interactions. The purpose of this document is to cover these concerns and explain HyClone's approach to them.
This webinar will outline a number of approaches to understanding and managing increased titers in commercial biopharmaceutical production, and explore the impact of titer on downstream chromatography steps, buffer preparation and hold steps, and practical techniques that can be used to alleviate bottlenecks.
Mani Krishnan, director of processing systems with EMD Millipore, discusses the challenges of single-use technologies, including scale limitations and cost of single-use, and how technology is adapting to those challenges. EMD Millipore highlighted the Mobius CellReady single-use bioreactor at the exhibition.